Home
News
Create
Screeners
Insights
Rekvina Laboratories
39.
87
+0.78
(+2.00%)
Market Cap
₹24.07 Cr
PE Ratio
-100.23
Industry
Healthcare
Buy
Sell
Company Performance:
1D
+2.00%
1M
+33.34%
6M
+463.14%
1Y
+463.14%
5Y
+954.76%
View Company Insights
Latest news about Rekvina Laboratories
Rekvina Laboratories Discloses Voting Results for EGM on Capital Restructuring
13 hrs ago
Today
Rekvina Laboratories Limited has disclosed official voting results for its Extra-Ordinary General Meeting held on April 10, 2026, showing unanimous approval of all six proposed resolutions by shareholders. The resolutions covered share capital increase, articles alteration, investment limits expansion, related party transactions, and preferential equity issuance for both cash and non-cash considerations, demonstrating strong shareholder support for the company's capital restructuring initiatives.
Rekvina Laboratories Claims Exemption from Annual Secretarial Compliance Report for FY26
4 days ago
Rekvina Laboratories Submits Q4FY26 Dematerialisation Compliance Certificate to BSE
4 days ago
Rekvina Laboratories Open Offer: Detailed Public Statement Published for 26% Stake Acquisition
Mar 25, 2026
Rekvina Laboratories Schedules EGM for April 10 to Approve Capital Restructuring
Mar 18, 2026
More news about Rekvina Laboratories
17
Mar 26
Rekvina Laboratories Discloses Open Offer Public Announcement to BSE
Rekvina Laboratories Limited has formally disclosed to BSE Limited the receipt of a public announcement for an open offer by three acquirers - Surbhit Mukesh Shah, Amit Mukesh Shah, and Dhruvalkumar Patel. The offer seeks to acquire 28,90,100 equity shares at ₹10 per share, representing 26% of expanded share capital with total consideration of ₹2,89,01,000. The transaction was triggered by a share exchange agreement for acquiring Radiant Parenterals Limited, managed by Vivro Financial Services under SEBI regulations.
Rekvina Laboratories
39.
87
+
0.
78
(+
2.
00
%)
1 Year Returns:
+463.14%
Industry Peers
Sun Pharmaceutical
1,654.90
(-
3.
62
%)
Divis Laboratories
6,116.50
(+
2.
76
%)
Torrent Pharmaceuticals
4,155.20
(+
1.
48
%)
Lupin
2,333.80
(+
1.
69
%)
Dr Reddys Laboratories
1,232.20
(+
1.
68
%)
Cipla
1,229.50
(+
0.
42
%)
Zydus Life Science
915.40
(+
1.
46
%)
Mankind Pharma
2,079.00
(+
1.
21
%)
Aurobindo Pharma
1,349.40
(+
0.
67
%)
Alkem Laboratories
5,440.00
(+
1.
29
%)
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO